Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Charlotte Høybye"'
Autor:
Mikael Lehtihet, Ylva Bonde, Lena Beckman, Katarina Berinder, Charlotte Hoybye, Mats Rudling, John H Sloan, Robert J Konrad, Bo Angelin
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148802 (2016)
Hepcidin reduces iron absorption by binding to the intestinal iron transporter ferroportin, thereby causing its degradation. Although short-term administration of testosterone or growth hormone (GH) has been reported to decrease circulating hepcidin
Externí odkaz:
https://doaj.org/article/99eaa4f7ebda4a72bc92051cfeda8ac6
Autor:
Denise H. van Abswoude, Karlijn Pellikaan, Naomi Nguyen, Anna G. W. Rosenberg, Kirsten Davidse, Franciska M. E. Hoekstra, Ilse M. Rood, Christine Poitou, Graziano Grugni, Charlotte Høybye, Tania P. Markovic, Assumpta Caixàs, Antonino Crinò, Sjoerd A. A. van den Berg, Aart J. van der Lely, Laura C. G. de Graaff
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/4bb7a1911f2d4e0e918bd1cd80546a0c
Autor:
Denise H. van Abswoude, Karlijn Pellikaan, Naomi Nguyen, Anna G. W. Rosenberg, Kirsten Davidse, Franciska M. E. Hoekstra, Ilse M. Rood, Christine Poitou, Graziano Grugni, Charlotte Høybye, Tania P. Markovic, Assumpta Caixàs, Antonino Crinò, Sjoerd A. A. van den Berg, Aart J. van der Lely, Laura C. G. de Graaff
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundPrader-Willi syndrome (PWS) is a rare, complex, genetic disorder characterized by hyperphagia, hypotonia, delayed psychomotor development, low muscle mass and hypothalamic dysfunction. Adults with PWS often have obesity, hypertension and ty
Externí odkaz:
https://doaj.org/article/b7fe49a89b8d4fd9b087a1e6cebb9573
Autor:
Denise H van Abswoude, Karlijn Pellikaan, Anna G W Rosenberg, Kirsten Davidse, Muriel Coupaye, Charlotte Høybye, Tania P Markovic, Graziano Grugni, Antonino Crinò, Assumpta Caixàs, Christine Poitou, Helena Mosbah, Tessa Weir, Leo A van Vlimmeren, Joost P H J Rutges, Luuk W L De Klerk, M Carola Zillikens, Aart J van der Lely, Laura C G de Graaff
Publikováno v:
The Journal of clinical endocrinology and metabolism, 108(1), 59-84. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 108, 59-84
Journal of Clinical Endocrinology and Metabolism, 108, 1, pp. 59-84
Journal of Clinical Endocrinology and Metabolism, 108, 59-84
Journal of Clinical Endocrinology and Metabolism, 108, 1, pp. 59-84
Context Prader–Willi syndrome (PWS) is a rare complex genetic syndrome, characterized by delayed psychomotor development, hypotonia, and hyperphagia. Hormone deficiencies such as hypogonadism, hypothyroidism, and growth hormone deficiency are commo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29258b3d285e57a56e73ef6f3e01d415
https://pure.eur.nl/en/publications/5afaaaf1-ca00-4352-bab9-6b2663240847
https://pure.eur.nl/en/publications/5afaaaf1-ca00-4352-bab9-6b2663240847
Autor:
Maria Petersson, Charlotte Höybye
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 8, Pp 8767-8779 (2024)
Prader–Willi Syndrome (PWS) is a rare genetic disorder typically characterized by decreased social interaction, hyperphagia, poor behavioral control and temper tantrums, together with a high risk of morbid obesity unless food intake is controlled.
Externí odkaz:
https://doaj.org/article/1f43ccd753bd419289bb63ee1f570171
Autor:
Constanze Lämmer, Philippe Backeljauw, Maite Tauber, Shankar Kanumakala, Sandro Loche, Karl Otfried Schwab, Roland Pfäffle, Charlotte Höybye, Elena Lundberg, Jovanna Dahlgren, Anna E. Ek, Tadej Battelino, Berit Kriström, Altaher Esmael, Markus Zabransky
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 15 (2024)
Background: Recombinant human growth hormone (rhGH, somatropin) therapy is approved in children with Prader–Willi syndrome (PWS). Objectives: To report safety and effectiveness data for children with PWS treated with biosimilar rhGH (Omnitrope ® ,
Externí odkaz:
https://doaj.org/article/f04e838397bc42f1976fe16a970231a2
Autor:
Karlijn Pellikaan, Yassine Ben Brahim, Anna G. W. Rosenberg, Kirsten Davidse, Christine Poitou, Muriel Coupaye, Anthony P. Goldstone, Charlotte Høybye, Tania P. Markovic, Graziano Grugni, Antonino Crinò, Assumpta Caixàs, Talia Eldar-Geva, Harry J. Hirsch, Varda Gross-Tsur, Merlin G. Butler, Jennifer L. Miller, Paul-Hugo M. van der Kuy, Sjoerd A. A. van den Berg, Jenny A. Visser, Aart J. van der Lely, Laura C. G. de Graaff
Publikováno v:
Journal of Clinical Medicine; Volume 10; Issue 24; Pages: 5781
Journal of Clinical Medicine
Journal of Clinical Medicine, MDPI, 2021, 10 (24), pp.5781. ⟨10.3390/jcm10245781⟩
Journal of Clinical Medicine, Vol 10, Iss 5781, p 5781 (2021)
Journal of Clinical Medicine, 10(24):5781. Multidisciplinary Digital Publishing Institute (MDPI)
Journal of Clinical Medicine
Journal of Clinical Medicine, MDPI, 2021, 10 (24), pp.5781. ⟨10.3390/jcm10245781⟩
Journal of Clinical Medicine, Vol 10, Iss 5781, p 5781 (2021)
Journal of Clinical Medicine, 10(24):5781. Multidisciplinary Digital Publishing Institute (MDPI)
International audience; Prader-Willi syndrome (PWS) is a rare neuroendocrine genetic syndrome. Characteristics of PWS include hyperphagia, hypotonia, and intellectual disability. Pituitary hormone deficiencies, caused by hypothalamic dysfunction, are
Autor:
Charlotte Höybye, Beverly M K Biller, Jean-Marc Ferran, Murray B Gordon, Nicky Kelepouris, Navid Nedjatian, Anne H Olsen, Matthias M Weber
Publikováno v:
Endocrine Connections, Vol 12, Iss 1, Pp 1-13 (2022)
Adult growth hormone deficiency (AGHD) is associated with an increased risk of cardiovascular (CV) disease. Long-term growth hormone (GH) trea tment could improve CV outcomes. The objective of this study was to evaluate CV disease risk in patients wi
Externí odkaz:
https://doaj.org/article/21868611a031471599f8d579043b1b21
Autor:
Christine Poitou, Anthony Holland, Charlotte Höybye, Laura C G de Graaff, Sandrine Bottius, Berit Otterlei, Maithé Tauber
Publikováno v:
Endocrine Connections, Vol 12, Iss 1, Pp 1-11 (2022)
Prader–Willi syndrome (PWS), the most common form of syndromic obesity, is a complex neurodevelopmental genetic disorder including obesity with hyperphagia, endocrine and metabolic disorders and also psychiatric disorders. The most frequent endocri
Externí odkaz:
https://doaj.org/article/8dbc53aa9f864b929cd40aede6500eec